These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3992030)

  • 1. Applicability of capillary gas liquid chromatography to the measurement of free fraction of disopyramide in human plasma.
    Kapil RP; Axelson JE; Lalka D; Edwards DJ; Kerr CR
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):153-6. PubMed ID: 3992030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantitation of disopyramide and its mono-dealkylated metabolite in human plasma by fused-silica capillary gas chromatography using nitrogen-phosphorus specific detection.
    Kapil RP; Abbott FS; Kerr CR; Edwards DJ; Lalka D; Axelson JE
    J Chromatogr; 1984 May; 307(2):305-21. PubMed ID: 6736179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disopyramide: clinical indications, pharmacokinetics and laboratory assessment.
    Taylor EH; Pappas AA
    Ann Clin Lab Sci; 1986; 16(4):289-95. PubMed ID: 2427003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics.
    Lima JJ; Boudoulas H; Blanford M
    J Pharmacol Exp Ther; 1981 Dec; 219(3):741-7. PubMed ID: 7299695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of disopyramide and mono-N-dealkyldisopyramide enantiomers in human plasma by capillary electrophoresis.
    Jabor VA; Lanchote VL; Bonato PL
    Electrophoresis; 2001 Apr; 22(7):1406-12. PubMed ID: 11379964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetic and pharmacodynamic effects of varying the free fraction of disopyramide.
    Shaw LM; Doherty JU; Waxman HL; Josephson ME
    Angiology; 1987 Feb; 38(2 Pt 2):192-7. PubMed ID: 3826754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of disopyramide and mono-N-desisopropyl-disopyramide in serum by gas-liquid chromatography with nitrogen-selective detection.
    Brien JF; Nakatsu K; Armstrong PW
    J Pharmacol Methods; 1983 Jun; 9(4):295-308. PubMed ID: 6621050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of free disopyramide plasma concentrations using ultrafiltration and enzyme multiplied immunoassay.
    Raghow G; Meyer MC; Straughn AB
    Ther Drug Monit; 1985; 7(4):466-71. PubMed ID: 3909539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gas-liquid chromatographic method for the routine estimation of disopyramide in plasma or serum.
    Johnston A; McHaffie D
    J Chromatogr; 1978 May; 152(2):501-6. PubMed ID: 659546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid sample preparation and high performance liquid chromatographic determination of total and unbound serum disopyramide.
    Taylor EH; Nelson D; Taylor RD; Pappas AA
    Ther Drug Monit; 1986; 8(2):219-22. PubMed ID: 3726939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gas-chromatographic determination of disopyramide with nitrogen detection.
    Gal J; Brady JT; Kett J
    J Anal Toxicol; 1980; 4(1):15-9. PubMed ID: 6927045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disopyramide concentrations in saliva.
    Aitio ML; Virtanen R; Lammintausta R
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):68-72. PubMed ID: 7061181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of altered disopyramide binding on its pharmacologic response in rabbits.
    Huang JD; Oie S
    J Pharmacol Exp Ther; 1982 Nov; 223(2):469-71. PubMed ID: 7131300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gas-chromatographic determination of disopyramide and its mono-N-dealkylated metabolite in serum with use of a nitrogen-selective detector.
    Bredesen JE
    Clin Chem; 1980 Apr; 26(5):638-40. PubMed ID: 7261311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple gas-liquid chromatographic method for the measurement of disopyramide in blood-plasma or serum and in urine.
    Hayler AM; Flanagan RJ
    J Chromatogr; 1978 Jun; 153(2):461-71. PubMed ID: 659563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of fluorescence immunoassay for total and unbound serum concentrations of disopyramide.
    Lima JJ; Shields BJ; Howell LH; MacKichan JJ
    Ther Drug Monit; 1984; 6(2):203-10. PubMed ID: 6377599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gas chromatographic determination of diisopyramide in the presence of some butyrophenones in human plasma.
    Quaglio MP; Fagioli F; Minozzi L
    Boll Chim Farm; 1995 Jan; 134(1):34-8. PubMed ID: 7734125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disopyramide concentrations in human plasma and saliva: comparison of disopyramide concentrations in saliva and plasma unbound concentrations.
    Sagawa K; Mohri K; Shimada S; Shimizu M; Muramatsu J
    Eur J Clin Pharmacol; 1997; 52(1):65-9. PubMed ID: 9143870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intra-individual change in serum protein binding on the pharmacologic response of R- and S-disopyramide in the rabbit.
    Huang JD; Oie S
    Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):243-53. PubMed ID: 6635319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.